Related references
Note: Only part of the references are listed.T-cell responses in osteosarcoma patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55
G. J. Ullenhagad et al.
CLINICAL IMMUNOLOGY (2008)
Tumor-specific CD4+ T cells render the tumor environment permissive for infiltration by low-avidity CD8+ T cells
S. B. Justin Wong et al.
JOURNAL OF IMMUNOLOGY (2008)
Electroporation-based DNA immunisation: translation to the clinic
Alain Luxembourg et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Optimizing engagement of the immune system by anti-timor antibodies: an engineer's perspective
John R. Desjarlais et al.
DRUG DISCOVERY TODAY (2007)
Anti-idiotype antibodies in cancer treatment
A. Lopez-Diaz de Cerio et al.
ONCOGENE (2007)
Mimotope vaccines for cancer immunotherapy
Tumenjargal Sharav et al.
VACCINE (2007)
Autophagy in MHC class II antigen processing
Andrew B. Strawbridge et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55
Gustav J. Ullenhag et al.
CLINICAL CANCER RESEARCH (2006)
The DRiP hypothesis decennial: support, controversy, refinement and extension
Jonathan W. Yewdell et al.
TRENDS IN IMMUNOLOGY (2006)
Immunologic control of tumors by in vivo Fcγ receptor-targeted antigen loading in conjunction with double-stranded RNA-mediated immune modulation
A Bot et al.
JOURNAL OF IMMUNOLOGY (2006)
Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions
AM Boruchov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma
K Pritchard-Jones et al.
BRITISH JOURNAL OF CANCER (2005)
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
KM Dhodapkar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A novel CEA vaccine stimulates T cell proliferation, γIFN secretion and CEA specific CTL responses
T Parsons et al.
VACCINE (2004)
Cutting edge:: CD4+ T cell help can be essential for primary CD8+ T cell responses in vivo
JCE Wang et al.
JOURNAL OF IMMUNOLOGY (2003)
Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross-priming and direct priming?
CJM Melief
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
EM Janssen et al.
NATURE (2003)
Optimal colocalization of TCR and CD8 as a novel mechanism for the control of functional avidity
AG Cawthon et al.
JOURNAL OF IMMUNOLOGY (2002)
Inducing tumor immunity through the selective engagement of activating Fcγ receptors on dendritic cells
AM Kalergis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Cross-priming of cytotoxic T cells promoted by apoptosis-inducing tumor cell reactive antibodies?
N Selenko et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2002)
Cross-priming as a predominant mechanism for inducing CD8+ T cell responses in gene gun DNA immunization
JH Cho et al.
JOURNAL OF IMMUNOLOGY (2001)
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses
RPM Sutmuller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: Comparison of prophylaxis and therapy
A van Elsas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Randomized double-blind phase II survival study comparing immunization with the anti idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer
CA Maxwell-Armstrong et al.
BRITISH JOURNAL OF CANCER (2001)
Human anti-idiotypic antibodies can be good immunogens as they target Fc receptors on antigen-presenting cells allowing efficient stimulation of both helper and cytotoxic T-cell responses
LG Durrant et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Exogenous antigen targeted to FcγRI on myeloid cells is presented in association with MHC class I
PK Wallace et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Tumor-specific CD4+ T cells have a major post-licensing role in CTL mediated anti-tumor immunity
AL Marzo et al.
JOURNAL OF IMMUNOLOGY (2000)
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
U Schubert et al.
NATURE (2000)